{"title":"等离子分离膜的性能评价。","authors":"Changsheng Zhao, Xiaohua Zhang, Y. Yue","doi":"10.1046/J.1526-0968.2002.00330.X","DOIUrl":null,"url":null,"abstract":"Membrane plasma fractionation is an important part of double filtration plasmapheresis. We evaluated a newly developed polyethersulfone (PES) hollow-fiber plasma fractionation membrane, using 3 parameters: abnormal protein ratio (APRR), different protein ratio (DPR), and plasma filtration efficiency, except sieving coefficients. The APRR of the fractionation membrane was over 0.90, and the DPR changed after the plasma fractionation. We also compared the sieving coefficients of the PES hollow membrane with some commercial plasma fractionation membranes. The data were significant for the clinical use of the PES hollow-fiber fractionation membrane.","PeriodicalId":79755,"journal":{"name":"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis","volume":"12 1","pages":"86-8"},"PeriodicalIF":0.0000,"publicationDate":"2002-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Performance evaluation of plasma fractionation membrane.\",\"authors\":\"Changsheng Zhao, Xiaohua Zhang, Y. Yue\",\"doi\":\"10.1046/J.1526-0968.2002.00330.X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Membrane plasma fractionation is an important part of double filtration plasmapheresis. We evaluated a newly developed polyethersulfone (PES) hollow-fiber plasma fractionation membrane, using 3 parameters: abnormal protein ratio (APRR), different protein ratio (DPR), and plasma filtration efficiency, except sieving coefficients. The APRR of the fractionation membrane was over 0.90, and the DPR changed after the plasma fractionation. We also compared the sieving coefficients of the PES hollow membrane with some commercial plasma fractionation membranes. The data were significant for the clinical use of the PES hollow-fiber fractionation membrane.\",\"PeriodicalId\":79755,\"journal\":{\"name\":\"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis\",\"volume\":\"12 1\",\"pages\":\"86-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1046/J.1526-0968.2002.00330.X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1046/J.1526-0968.2002.00330.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Performance evaluation of plasma fractionation membrane.
Membrane plasma fractionation is an important part of double filtration plasmapheresis. We evaluated a newly developed polyethersulfone (PES) hollow-fiber plasma fractionation membrane, using 3 parameters: abnormal protein ratio (APRR), different protein ratio (DPR), and plasma filtration efficiency, except sieving coefficients. The APRR of the fractionation membrane was over 0.90, and the DPR changed after the plasma fractionation. We also compared the sieving coefficients of the PES hollow membrane with some commercial plasma fractionation membranes. The data were significant for the clinical use of the PES hollow-fiber fractionation membrane.